Recent research has demonstrated the association of MTHFR C677T polymorphism with an increased risk of tumors and particularly an increased risk of gastrointestinal and breast cancer, while MTHFR A1298C polymorphism has not been significantly associated with tumorigenesis. This evidence concerns the gene MTHFR and breast carcinoma.